{"id":564352,"date":"2026-08-26T14:00:00","date_gmt":"2026-08-26T12:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/in-addition-to-anti-ige-antibodies-the-guideline-recommends-anti-il-4%ce%b1-antibodies-and-btk-inhibition\/"},"modified":"2026-09-04T09:39:52","modified_gmt":"2026-09-04T07:39:52","slug":"in-addition-to-anti-ige-antibodies-the-guideline-recommends-anti-il-4%ce%b1-antibodies-and-btk-inhibition","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/in-addition-to-anti-ige-antibodies-the-guideline-recommends-anti-il-4%ce%b1-antibodies-and-btk-inhibition\/","title":{"rendered":"In addition to anti-IgE antibodies, the guideline recommends anti-IL-4\u03b1 antibodies and BTK inhibition"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>The 2026 revised edition of the international urticaria guidelines incorporates the latest findings on pathogenesis and treatment options. Chronic spontaneous urticaria (CSU) encompasses various immunological endotypes with implications for the selection of the appropriate biologic or \u201csmall molecules.\u201d In addition to omalizumab, dupilumab\u2014another monoclonal antibody\u2014is available in the EU as an add-on therapy; furthermore, the oral BTK inhibitor remibrutinib has since received EMA approval\u2014and remibrutinib was also recently approved in Switzerland.<\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fin-addition-to-anti-ige-antibodies-the-guideline-recommends-anti-il-4%25ce%25b1-antibodies-and-btk-inhibition%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>The 2026 revised edition of the international urticaria guidelines incorporates the latest findings on pathogenesis and treatment options. Chronic spontaneous urticaria (CSU) encompasses various immunological endotypes with implications for the&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fin-addition-to-anti-ige-antibodies-the-guideline-recommends-anti-il-4%25ce%25b1-antibodies-and-btk-inhibition%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":564353,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Chronic Urticaria: Treatment for Patients Unresponsive to Antihistamines  ","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11548,11331,11513,11340,11503],"tags":[100454,100452,100453,82458,28141,18018,72035,63710,13405,100456,100455,13392,84805,100458,100457,15545],"powerkit_post_featured":[],"class_list":["post-564352","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-allergology-and-clinical-immunology","category-congress-reports","category-dermatology-and-venereology","category-studies","tag-anti-ige-antibodies","tag-anti-il-4-antibodies","tag-antihistamine-refractory","tag-barzolvolimab-en","tag-biologic","tag-chronic-spontaneous-urticaria","tag-chronic-urticaria","tag-csu-en","tag-dupilumab-en","tag-embarq-csu","tag-liberty-csu-cupid","tag-omalizumab-en","tag-remibrutinib-en","tag-remix","tag-rhapsido","tag-small-molecules-en","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-12 10:59:13","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":564355,"slug":"la-recommandation-preconise-outre-les-anticorps-anti-ige-lutilisation-danticorps-anti-il-4%ce%b1-et-linhibition-de-la-btk","post_title":"La recommandation pr\u00e9conise, outre les anticorps anti-IgE, l'utilisation d'anticorps anti-IL-4\u03b1 et l'inhibition de la BTK","href":"https:\/\/medizinonline.com\/fr\/la-recommandation-preconise-outre-les-anticorps-anti-ige-lutilisation-danticorps-anti-il-4%ce%b1-et-linhibition-de-la-btk\/"},"it_IT":{"locale":"it_IT","id":564358,"slug":"le-linee-guida-raccomandano-oltre-agli-anticorpi-anti-ige-anche-gli-anticorpi-anti-il-4%ce%b1-e-linibizione-della-btk","post_title":"Le linee guida raccomandano, oltre agli anticorpi anti-IgE, anche gli anticorpi anti-IL-4\u03b1 e l\u2019inibizione della BTK","href":"https:\/\/medizinonline.com\/it\/le-linee-guida-raccomandano-oltre-agli-anticorpi-anti-ige-anche-gli-anticorpi-anti-il-4%ce%b1-e-linibizione-della-btk\/"},"pt_PT":{"locale":"pt_PT","id":564361,"slug":"a-diretriz-recomenda-para-alem-dos-anticorpos-anti-ige-tambem-os-anticorpos-anti-il-4%ce%b1-e-a-inibicao-da-btk","post_title":"A diretriz recomenda, para al\u00e9m dos anticorpos anti-IgE, tamb\u00e9m os anticorpos anti-IL-4\u03b1 e a inibi\u00e7\u00e3o da BTK","href":"https:\/\/medizinonline.com\/pt-pt\/a-diretriz-recomenda-para-alem-dos-anticorpos-anti-ige-tambem-os-anticorpos-anti-il-4%ce%b1-e-a-inibicao-da-btk\/"},"es_ES":{"locale":"es_ES","id":564364,"slug":"la-guia-recomienda-ademas-de-los-anticuerpos-anti-ige-los-anticuerpos-anti-il-4%ce%b1-y-la-inhibicion-de-la-btk","post_title":"La gu\u00eda recomienda, adem\u00e1s de los anticuerpos anti-IgE, los anticuerpos anti-IL-4\u03b1 y la inhibici\u00f3n de la BTK","href":"https:\/\/medizinonline.com\/es\/la-guia-recomienda-ademas-de-los-anticuerpos-anti-ige-los-anticuerpos-anti-il-4%ce%b1-y-la-inhibicion-de-la-btk\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/564352","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=564352"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/564352\/revisions"}],"predecessor-version":[{"id":564354,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/564352\/revisions\/564354"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/564353"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=564352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=564352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=564352"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=564352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}